Nosocomial pneumonia

Therapeutische Umschau

Volumn 58, Issue 10, 2001, Pages 609-613

  Ewig, S ^a   Walger, P ^a   Vetter, H ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFAMANDOLE NAFATE; CEFEPIME; CEFMENOXIME; CEFOTAXIME; CEFOTIAM; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CEFUROXIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; MAXOPIME; MEROPENEM; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TAZOBACTAM; TEICOPLANIN; TOBRAMYCIN; TOBRAMYCIN SULFATE; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL PNEUMONIA; DISEASE COURSE; DISEASE SEVERITY; ENTEROBACTERIACEAE; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; MEDICAL ASSESSMENT; MICROBIOLOGICAL EXAMINATION; PATHOGENICITY; RESPIRATORY TRACT EXAMINATION; RISK FACTOR; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TIME; TREATMENT FAILURE; CROSS INFECTION; DOSE RESPONSE; DRUG ADMINISTRATION;

ANTI-BACTERIAL AGENTS; BACTERIOLOGICAL TECHNIQUES; CROSS INFECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HUMANS; MICROBIAL SENSITIVITY TESTS; PNEUMONIA, BACTERIAL; RISK FACTORS;

EID: 0034740578     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.58.10.609     Document Type: Article

References (18)

1. Incidence and risk factors for ventilator-associated pneumonia in critically ill patients
2. Pneumonie
3. Microbial causes of ventilator-associated pneumonia
4. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria
5. Bacterial colonization patterns in mechanically ventilated patients with traumatic and medical head injury. Incidence, risk factors, and association with ventilator-associated pneumonia
6. Nosocomial respiratory tract infections in multiple trauma patients. Influence of level of consciousness with implications for therapy
7. Risk factors for infection by Pseudomonas aeruginosa in patients with ventilator-associated pneumonia
8. Nosocomial respiratory infections with gram-negative bacilli: The significance of colonization of the respiratory tract
9. Clinical diagnosis of ventilator-associated pneumonia revisited: Comparative validation using immediate postmortem lung biopsies
10. Diagnostic value of quantitative cultures of bronchoalveolar lavage und telescoping plugged catheters in mechanically ventilated patients with bacterial pneumonia
11. Flexible bronchoscopy in nosocomial pneumonia
12. Hospital-acquired pneumonia in adults; diagnosis, assessment, initial severity, and prevention. A consensus statement
13. Nosokomiale Pneumonie. Empfehlungen zur Therapie und Prophylaxe
14. Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients
15. Treatment of severe pneumonia in hospitalized patients: Results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem/cilastatin
16. Ceftazidime monotherapy versus ceftriaxone/tobramycin for serious hospital-acquired Gram-negative infections
17. Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis
18. Antimicrobial therapy of ventilator-associated pneumonia. How to select an appropriate drug regimen